通瘀Ⅰ号方改善老年糖尿病患者血栓前状态的临床研究

目的：探讨中药通瘀I号方改善老年糖尿病血栓前状态的作用机理。方法：选择有血栓前状态伴有瘀血证的老年糖尿病患者62例，随机分为两组，在常规基础治疗上分别加用通瘀I号方（中药组32例）和肠溶阿司匹林（对照组30例）治疗2个月，并观察两组患者症候疗效及治疗前后的相关指标。结果：中药组显效14例，有效16例，无效2例，总有效率为93．8％；对照组分别为6例、14例、10例和66．7％；两组总有效率比较，差异有显著性（P＜0．01）。中药组血栓素B2下降程度与对照组相似，中药组的血小板颗粒膜蛋白（GMP－140）、空腹血糖水平较治疗前明显下降（P＜0．01），治疗后两组比较，差异均有显著性（P＜0．05）。结论：通瘀I号方能改善糖尿病的血栓前状态和糖尿病瘀血证候。其主要作用机理可能与改善GMP－140的含量等有关。

Clinical Study on Effect of Tongyu No. I in Improving Prethrombotic State of Senile Diabetes Mellitus

Objective: To explore the therapeutic mechanism of Tongyu No. I (TY 1) in improving prethrombotic state of senile diabetes mellitus. Methods: Sixty two patients of diabetes mellitus with prethrombotic state and blood stasis Syndrome were selected and divided randomly into two groups, 32 in the treated group and 30 in the control group. The two groups were treated by conventional therapy, combined with additional TY 1 (treated group) and aspirin (control group) respectively for 2 months. And the clinical effect as well as relevant criteria in both groups before and after treatment were observed. Results: In the treated group, treatment showed markedly effective in 14 cases, effective in 16 and ineffective in 2, the total effective rate being 93.8%. In the control group,the corresponding values were 6, 14, 10 and 66.7% respectively. Comparison of the total effective rate in the two groups showed significant difference (P<0 01). After treatment, the treated group showed lowering in plasma TXB 2 similar to that in the control group, while the decrease of GMP 140 and fasting blood glucose levels was significant as compared with before treatment (P<0 01) and the difference was significant between the two groups (P<0 05) after treatment. Conclusion: TY 1 could improve the prethrombotic state and blood stasis Syndrome in patients of diabetes mellitus, the main therapeutic mechanism might be correlated to the lowering of GMP 140 content.